KAZIA CEO, DR. JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE CANCER MOONSHOT

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, has been invited to the White House to...

Related Keywords

Australia ,White House ,District Of Columbia ,United States ,Sydney ,New South Wales ,American ,Jane Lowe ,Joe Biden ,John Friend ,Jill Biden ,Cancer Moonshot Brain Cancers Forum On Glioblastoma ,Genentech ,Society For Melanoma Research ,Prnewswire Kazia Therapeutics Limited ,Kazia Therapeutics Limited ,Oncology Consortium ,Global Coalition For Adaptive Research ,American Association For Cancer Research ,Kazia Therapeutics ,Ir Department ,Brain Cancers Forum ,Diffuse Intrinsic Pontine Glioma ,Therapeutics Limited ,Cancer Moonshot Brain Cancers Forum ,President Joe Biden ,First Lady ,Cancer Moonshot ,Global Coalition ,Adaptive Research ,Pacific Pediatric Neuro Oncology Consortium ,American Association ,Cancer Research ,Orphan Drug Designation ,Fast Track Designation ,Rare Pediatric Disease Designation ,Orphan Designation ,Annual Report ,Chief Executive ,More Information ,Please Contact ,